Table 1.
Patient demographics
| Characteristics | Germany | Italy | Spain | UK | US | Total |
|---|---|---|---|---|---|---|
| Patients (n) | 146 | 100 | 100 | 125 | 511 | 982 |
| Type of MS (self-reported), % | ||||||
| RRMS | 43 | 40 | 42 | 41 | 66a–d | 46 |
| SPMS | 26e | 35e | 42a,d,e | 26e | 18 | 29 |
| PPMS | 11 | 10 | 9 | 17e | 8 | 11 |
| PRMS | 13b–e | 5 | 4 | 6 | 4 | 6 |
| Other/not sure | 7 | 10 | 3 | 10 | 5 | 7 |
| Mean (SD) age (years) | 44 (10)c | 42 (12) | 40 (10) | 49 (13)a–c | 50 (13)a–c | 45 (12) |
| Female, % | 71c | 59c | 44 | 74b,c | 69c | 63 |
| Mean (median) time since MS diagnosis (years) | 11.8 (10)b,c | 8.6 (5) | 6.9 (5) | 12.3 (10)b,c | 14.3 (12)a–c | 10.8 (8) |
| Participation in clinical trial for MS, % | ||||||
| Yes, currently participating | 9d | 13d,e | 10d,e | 2 | 5 | 8 |
| Yes, participated in the past but not currently | 13 | 24a,e | 28a,e | 19e | 10 | 19 |
| No, I have never participated | 78b,c | 63 | 62 | 79b,c | 85b,c | 74 |
Notes: Weights were applied to the total data to give each country equal representation in the overall results.
a
Significantly different than Germany.
b
Significantly different than Italy.
c
Significantly different than Spain.
d
Significantly different than the UK.
e
Significantly different than the US.
Abbreviations: MS, multiple sclerosis; PPMS, primary progressive multiple sclerosis; PRMS, progressive relapsing multiple sclerosis; RRMS, relapsing-remitting multiple sclerosis; SD, standard deviation; SPMS, secondary progressive multiple sclerosis.